PositronMed

PositronMed is a specialized diagnostic imaging company dedicated to the early detection and management of neurodegenerative conditions, particularly Alzheimer's disease. Utilizing state-of-the-art Positron Emission Tomography (PET) and CT technology, the company identifies critical biomarkers such as amyloid plaques and tau tangles in the brain. Their clinical services provide patients and physicians with high-resolution insights into brain health, enabling earlier intervention and more accurate monitoring of cognitive decline. PositronMed also focuses on assessing traumatic brain injuries and chronic traumatic encephalopathy in athletes and high-risk individuals.